Bellvitge Biomedical Research Institute - IDIBELL

A new genomic study has found a higher level of antibiotic resistance in #Haemophilus parainfluenzae than H. influenzae, two pathogenic bacteria. These results highlight the importance of monitoring resistance levels, especially in H. parainfluenzae. https://lnkd.in/dHJv6YYk

A study describes how #insulinomas, a rare type of pancreatic beta cell tumour, is formed. The cause is a change in the epigenetic pattern of the beta cells of the pancreas, which overexpress oncogenes and genes related to insulin production, thus altering their functioning. https://lnkd.in/gv6gBXDw

A study proves the advantages of administering #chemotherapy before #surgery in stage II and III #breastcancer: it facilitates surgery and offers prognostic value. The 10-year survival rate is 84%, and 96% of patients who have a complete response to chemotherapy do not metastasize. Study by Bellvitge Biomedical Research Institute - IDIBELL, Institut Català d'Oncologia (ICO) and Hospital Universitari de Bellvitge https://lnkd.in/dxeTrE5T

A new bioinformatics algorithm improves the genetic detection of #Lynch and #CMMRD cancer predisposition syndromes. Researcjers have developed a test that will facilitate genetic assessment, speed up the diagnosis process and therapeutic decision-making in patients with suspected hereditary cancer. https://lnkd.in/d3uB7imw

Today, the Mutua Madrileña Foundation presented the Grants for Health Research, supporting 18 research institutes and hospitals across Spain. Among the recipients, Dr. Miguel HUESO from #IDIBELL and Hospital Universitari de Bellvitge received funding for his project "BioDigital Synergy," focusing on bioartificial kidneys. This initiative aims to develop advanced tools for clinical use and accelerate drug development.

We are hiring! 📢 We are currently seeking a Lawyer with experience in reviewing and negotiating contracts in civil law, preferably with expertise in contract law. If you are interested in learning more and are looking for a new opportunity in the field of biomedical research, please apply through the following link: https://shorturl.at/gLJXk

Researchers from Hospital Universitari de Bellvitge and #IDIBELL have participated in a #clinicaltrial that has demonstrated the efficacy of sebetralstat, a new oral treatment for hereditary #angioedema attacks. Published in NEJM Group, the results of this study are the first advance in a decade in the on-demand treatment of this disease.

The genetic test hs-MSI will improve the diagnosis of #CMMRD, a rare cancer predisposition syndrome in children. Developed by researchers at Bellvitge Biomedical Research Institute - IDIBELL and Institut Català d'Oncologia (ICO), this tool will help offer more effective treatments and a better genetic counseling to affected families. https://lnkd.in/dERzCnxF

Researchers discover biomarkers that predict response to #immunotherapy in skin carcinoma. Published in #Nature Communications, this finding would allow personalizing the treatment of skin carcinoma and thus increase the patients quality of life. https://lnkd.in/d4aZKRa7

A recent study by Bellvitge University Hospital and IDIBELL, presented at the European Congress of Microbiology and Infectious Diseases, highlights Fecal Microbiota Transplantation as a safe and effective alternative to antibiotics for C. difficile infection.